Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29476 | 185 | 25.7 | 31% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 154 | 3 | PSYCHIATRY//ALEXITHYMIA//PSYCHIAT | 62481 |
| 207 | 2 | PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION | 21074 |
| 29476 | 1 | AMINEPTINE HCL//DECREASED POSITIVE MOOD SYMPTOMS//DOG MAN | 185 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AMINEPTINE HCL | authKW | 165057 | 1% | 100% | 1 |
| 2 | DECREASED POSITIVE MOOD SYMPTOMS | authKW | 165057 | 1% | 100% | 1 |
| 3 | DOG MAN | authKW | 165057 | 1% | 100% | 1 |
| 4 | DUAL DOPAMINE AND NOREPINEPHRINE REUPTAKE INHIBITORS | authKW | 165057 | 1% | 100% | 1 |
| 5 | DYSTHYMIC DISORDER DRUG THERAPY | authKW | 165057 | 1% | 100% | 1 |
| 6 | ICM 10 | authKW | 165057 | 1% | 100% | 1 |
| 7 | INCLUSION AND BRUSH TYPE STATIONARY PHASES | authKW | 165057 | 1% | 100% | 1 |
| 8 | MESH MAX 10 MAJOR DEPRESSIVE DISORDER | authKW | 165057 | 1% | 100% | 1 |
| 9 | OPERANT BEHAVIORAL MODEL | authKW | 165057 | 1% | 100% | 1 |
| 10 | PLASTIC MEMBRANE ELECTRODE | authKW | 165057 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Psychiatry | 1323 | 31% | 0% | 57 |
| 2 | Pharmacology & Pharmacy | 918 | 42% | 0% | 77 |
| 3 | Psychology, Clinical | 161 | 7% | 0% | 13 |
| 4 | Medicine, General & Internal | 105 | 12% | 0% | 23 |
| 5 | Chemistry, Analytical | 70 | 10% | 0% | 18 |
| 6 | Telecommunications | 61 | 5% | 0% | 10 |
| 7 | Clinical Neurology | 50 | 9% | 0% | 16 |
| 8 | Psychology | 30 | 3% | 0% | 6 |
| 9 | Neurosciences | 28 | 10% | 0% | 18 |
| 10 | Ergonomics | 21 | 1% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | UNIV GEORGIA PHARM | 165057 | 1% | 100% | 1 |
| 2 | PETER ROTHWELL | 33010 | 1% | 20% | 1 |
| 3 | DISCOVERY DMPK | 7951 | 1% | 2% | 2 |
| 4 | LEAD GENERAT | 5737 | 1% | 2% | 2 |
| 5 | WAIKATO CLIN | 3297 | 1% | 1% | 2 |
| 6 | CLIN PHARM PROGRAM | 3055 | 1% | 2% | 1 |
| 7 | SCI DEV GRP | 2537 | 1% | 2% | 1 |
| 8 | PHARM PL SCI | 2142 | 1% | 1% | 1 |
| 9 | MASSACHUSETTS GEN HOSP MED | 1812 | 1% | 1% | 1 |
| 10 | PSYCHOPHARMACOL UNIT | 1230 | 1% | 0% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTERNATIONAL PHARMACOPSYCHIATRY | 96899 | 4% | 7% | 8 |
| 2 | ELECTRICAL COMMUNICATION | 53068 | 4% | 4% | 8 |
| 3 | VRACHEBNOE DELO | 17217 | 4% | 1% | 8 |
| 4 | FOLIA NEUROPSIQUIATRICA | 6111 | 1% | 4% | 1 |
| 5 | CLINICAL NEUROPHARMACOLOGY | 5578 | 5% | 0% | 9 |
| 6 | JOURNAL OF CLINICAL PSYCHIATRY | 3347 | 6% | 0% | 12 |
| 7 | PHARMACOPSYCHIATRIA | 1397 | 1% | 1% | 1 |
| 8 | PHARMACOPSYCHIATRY | 1312 | 2% | 0% | 4 |
| 9 | ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY | 1298 | 1% | 0% | 2 |
| 10 | JOURNAL OF BEHAVIORAL ASSESSMENT | 1239 | 1% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KINNEY, JL , (1985) NOMIFENSINE MALEATE - A NEW 2ND-GENERATION ANTIDEPRESSANT.CLINICAL PHARMACY. VOL. 4. ISSUE 6. P. 625-636 | 23 | 53% | 25 |
| 2 | YU, J , MATHISEN, DE , BURDETTE, D , BROWN, DG , BECKER, C , AHARONY, D , (2010) IDENTIFICATION OF MULTIPLE GLUTATHIONE CONJUGATES OF 8-AMINO-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE MALEATE (NOMIFENSINE) IN LIVER MICROSOMES AND HEPATOCYTE PREPARATIONS: EVIDENCE OF THE BIOACTIVATION OF NOMIFENSINE.DRUG METABOLISM AND DISPOSITION. VOL. 38. ISSUE 1. P. 46-60 | 8 | 44% | 7 |
| 3 | GARATTINI, S , (1997) PHARMACOLOGY OF AMINEPTINE, AN ANTIDEPRESSANT AGENT ACTING ON THE DOPAMINERGIC SYSTEM: A REVIEW.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. VOL. 12. ISSUE . P. S15-S19 | 9 | 56% | 13 |
| 4 | ZAPADNYUK, VI , (1990) PROBLEMS AND PERSPECTIVES OF GERIATRIC PHARMACOLOGY.FARMAKOLOGIYA I TOKSIKOLOGIYA. VOL. 53. ISSUE 3. P. 4-8 | 11 | 55% | 0 |
| 5 | RICHE, C , LACHATRE, G , GUEDES, Y , MOCAER, E , NICOT, G , (1989) PHARMACOKINETICS OF AMINEPTINE AFTER SINGLE-DOSE, REPEATED TREATMENT AND STUDY OF THE AT-RISK POPULATIONS.CLINICAL NEUROPHARMACOLOGY. VOL. 12. ISSUE . P. S32-S40 | 7 | 88% | 4 |
| 6 | ULU, ST , (2012) SPECTROFLUORIMETRIC DETERMINATION OF NOMIFENSINE IN HUMAN PLASMA AND URINE BY DERIVATIZATION WITH FLUORESCAMINE.LUMINESCENCE. VOL. 27. ISSUE 1. P. 80-83 | 6 | 43% | 1 |
| 7 | HEFNAWY, MM , STEWART, JT , (1999) RESOLUTION OF NOMIFENSINE ENANTIOMERS ON SELECTED ACHIRAL AND CHIRAL STATIONARY PHASES USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY.ANALYTICAL LETTERS. VOL. 32. ISSUE 1. P. 159 -171 | 7 | 44% | 5 |
| 8 | YU, JA , BROWN, DG , BURDETTE, D , (2010) IN VITRO METABOLISM STUDIES OF NOMIFENSINE MONOOXYGENATION PATHWAYS: METABOLITE IDENTIFICATION, REACTION PHENOTYPING, AND BIOACTIVATION MECHANISM.DRUG METABOLISM AND DISPOSITION. VOL. 38. ISSUE 10. P. 1767-1778 | 6 | 33% | 7 |
| 9 | BORAL, GC , SHAH, LP , (1989) THE BENEFICIAL-EFFECTS OF AMINEPTINE (SURVECTOR 100) IN THE TREATMENT OF DEPRESSION - PRELIMINARY-RESULTS OF AN INDIAN MULTICENTER TRIAL.CLINICAL NEUROPHARMACOLOGY. VOL. 12. ISSUE . P. S51-S57 | 4 | 100% | 1 |
| 10 | ARANDA, AH , IGLESIAS, AG , (1995) PSYCHOTIC REACTION IN A CASE OF ADDICTION TO AMINEPTINE.FOLIA NEUROPSIQUIATRICA. VOL. 30. ISSUE 1. P. 79-86 | 6 | 50% | 0 |
Classes with closest relation at Level 1 |